MedPath

Online Meditation for Mild Cognitive Impairment and Mild Dementia

Not Applicable
Not yet recruiting
Conditions
Mild Cognitive Impairment (MCI)
Dementia
Registration Number
NCT06768450
Lead Sponsor
King's College London
Brief Summary

The study will look at whether online mindfulness meditation (OMM) is easy for older adults with mild cognitive impairment (MCI) and mild dementia to use. It will also see how OMM affects their mood, sleep, and quality of life.

The investigators will recruit 32 participants, divided into 4 groups of 8 people each.

Participants will:

* Attend an online mindfulness meditation class once a week for 8 weeks

* Practice at home for 20 minutes each day

* Keep a simple record of their practice and feelings

Detailed Description

This research aims to investigate the feasibility and acceptability of online meditation for older adults with mild cognitive impairment (MCI) and mild dementia in the UK and to explore its impact on cognitive function, mood, mindfulness, and quality of life. This study will recruit 32 participants with MCI and mild dementia. Participants will receive mindfulness meditation training in an online group-based format, with 8 participants per group in 4 waves. A qualified meditation teacher will lead the sessions via Microsoft Teams once a week for 8 weeks (lasting 2 to 2.5 hours per session).

The study outcomes will include feasibility of the intervention, acceptability to participants, cognitive function, mindfulness, and quality of life. Data will be collected at baseline and after the intervention. A paired t-test will compare pre- and post-intervention changes if the data meet assumptions of normal distribution and homogeneity of variance. Otherwise, non-parametric statistical analyses will be applied.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
32
Inclusion Criteria
  • Age 60 years or older.
  • MCI: Concern regarding a change in cognition, with impairment in one or more cognitive domains, including memory, executive function, attention, language, and visuospatial skills. Preservation of independence in functional abilities and does not meet the criteria for dementia, as described in the National Institute on Aging and Alzheimer's Association (NIA-AA) diagnostic guidelines.
  • Mild dementia: As described in the NIA-AA research framework, mild dementia is defined as substantial progressive cognitive impairment affecting several domains and/or neurobehavioral disturbances. Documented by the individual's report, an observer (e.g., a study partner) report, or by changes observed on longitudinal cognitive testing. Clearly evident functional impact on daily life, mainly affecting instrumental activities. No longer fully independent and requires occasional assistance with daily activities.
  • Access to an electronic device (e.g., smartphone, computer, or tablet) and the internet.
  • Ability and willingness to provide informed consent by signing the Consent Form.
Exclusion Criteria
  • Current active or past significant experience with meditation.
  • Clinically significant mental or physical health disorder beyond MCI or dementia that may affect cognition and/or the ability to complete the study (e.g., severe depression, suicidality, psychosis, post-traumatic stress disorder (PTSD), major psychiatric diagnoses, social anxiety (e.g., difficulty participating in a group setting), or severe impairments in eyesight, hearing, or upper limb motor movements).
  • Inability to commit to attending classes (e.g., planning to miss three or more classes).
  • Lack of proficiency in English.
  • Diagnosed with moderate or severe dementia.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Conversion ratethrough study completion, an average of 1 year

Conversion Rate= Number of participants enrolled / Number of potential participants contacted × 100%

Attrition ratethrough study completion, an average of 1 year

Attrition Rate (%)= Number of participants who dropped out / Total number of participants initially enrolled × 100%

Retention ratethrough study completion, an average of 1 year

Retention Rate (%)= Number of participants who completed the study / Number of participants initially enrolled × 100%

Client Satisfaction Questionnaireimmediately after the intervention

It is a standardized 8-item tool that has demonstrated good reliability and validity in mental health services. Items are scored from 1 (low satisfaction) to 4 (high satisfaction) with different descriptors for each response point. Total scores range from 8 to 32, with higher scores indicating greater satisfaction.

Secondary Outcome Measures
NameTimeMethod
Modified Telephone Interview for Cognitive Statusbaseline and immediately after the intervention

The Modified Telephone Interview for Cognitive Status is a brief, 13-item test of cognitive functioning with total scores ranging from 0 to 50. Questions of orientation, repetition, naming, and calculations are some of the items covered. Additionally, a 10-item non-semantically related word list is recalled both immediately and after a delay of about 5 minutes filled with distractor questions. Higher scores mean a better outcome.

Pittsburgh sleep quality indexbaseline and immediately after the intervention

It is a self-rated questionnaire which assesses sleep quality and disturbances over a 1-month time interval. Nineteen individual items generate seven component scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. The total scores range from 0 to 21. Higher scores mean a worse outcome.

Hospital anxiety and depression scalebaseline and immediately after the intervention

It is used in the setting of a general medical hospital outpatient clinic to assess the mental health of patients. It has two subscales (anxiety and depression), each with seven items and a score of 0-3 for each item, the total score is 21 respectively. Higher scores indicate a worse condition.

© Copyright 2025. All Rights Reserved by MedPath